Azazuddin Ahmed

1.5k total citations · 1 hit paper
6 papers, 519 citations indexed

About

Azazuddin Ahmed is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Azazuddin Ahmed has authored 6 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Azazuddin Ahmed's work include Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Azazuddin Ahmed is often cited by papers focused on Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Azazuddin Ahmed collaborates with scholars based in Romania, United States and Japan. Azazuddin Ahmed's co-authors include Cristian Guja, Elise Hardy, Juan P. Frías, Serge Jabbour, Peter Öhman, Fang Dong, Hui Wang, C. David Sjöström, Jasmine Choi and A.M. Moody and has published in prestigious journals such as Diabetes Care, The Lancet Diabetes & Endocrinology and Diabetes Obesity and Metabolism.

In The Last Decade

Azazuddin Ahmed

6 papers receiving 501 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial

2016 328 citations Juan P. Frías, Cristian Guja et al. The Lancet Diabetes & Endocrinology profile →

Peers

Azazuddin Ahmed

EDM

MB

SURGE

PHARM

PHYSI

Juan José Gorgojo Martínez Spain

Sayeh Tadayon Denmark

Desirée Thielke Denmark

Thinzar Min United Kingdom

Ros Swallow United Kingdom

Masato Kawaguchi United States

Tomoyuki Nishida Japan

R. Qiu United States

Knut Robert Andersen Germany

Laura Heenan United States

Juan José Gorgojo Martínez Spain

Azazuddin Ahmed

465 ×1.0

EDM

167 ×0.7

MB

166 ×0.8

SURGE

186 ×1.2

PHARM

96 ×2.0

PHYSI

Citations per year, relative to Azazuddin Ahmed Azazuddin Ahmed (= 1×) peers Juan José Gorgojo Martínez

Countries citing papers authored by Azazuddin Ahmed

Since Specialization

Citations

This map shows the geographic impact of Azazuddin Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azazuddin Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azazuddin Ahmed more than expected).

Fields of papers citing papers by Azazuddin Ahmed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azazuddin Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azazuddin Ahmed. The network helps show where Azazuddin Ahmed may publish in the future.

Co-authorship network of co-authors of Azazuddin Ahmed

This figure shows the co-authorship network connecting the top 25 collaborators of Azazuddin Ahmed. A scholar is included among the top collaborators of Azazuddin Ahmed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azazuddin Ahmed. Azazuddin Ahmed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jabbour, Serge, Juan P. Frías, Azazuddin Ahmed, et al.. (2020). Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial. Diabetes Care. 43(10). 2528–2536. 49 indexed citations

2.

Frías, Juan P., Elise Hardy, Azazuddin Ahmed, et al.. (2018). Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION ‐8 randomized controlled trial. Diabetes Obesity and Metabolism. 20(6). 1520–1525. 23 indexed citations

3.

Jabbour, Serge, Juan P. Frías, Cristian Guja, et al.. (2018). Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study. Diabetes Obesity and Metabolism. 20(6). 1515–1519. 38 indexed citations

4.

Jabbour, Serge, Juan P. Frías, Elise Hardy, et al.. (2018). Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial. Diabetes Care. 41(10). 2136–2146. 76 indexed citations

5.

Frías, Juan P., Cristian Guja, Elise Hardy, et al.. (2016). Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial. The Lancet Diabetes & Endocrinology. 4(12). 1004–1016. 328 indexed citations breakdown →

6.

Moody, A.M., et al.. (1995). Renin-producing leiomyosarcoma originating in the uterus. Clinical Oncology. 7(1). 52–53. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact